ENTITY
Gilead Sciences

Gilead Sciences (GILD US)

160
Analysis
Health Care • United States
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
more
Exchange Announcement • 07 Aug 2026 05:04

S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers

Exchange Announcement • 06 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 21 May 2026 04:15

Current Report (Form 8-K | Period ending 2026-05-14)

Exchange Announcement • 19 May 2026 04:15

424B5 | Prospectus

Exchange Announcement • 14 May 2026 20:46

424B5 | Prospectus

x